VVTM.V VVT Med Inc.

Healthcare Medical Devices TSX Venture Exchange
0.1500 CAD
Close of Nov 7, 2026
0.1500 0.4500
Market cap
CAD 10.9M
P/E
-
P/B
-
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is VVTM.V undervalued?

Graham number

The Graham number of VVT Med Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VVT Med Inc. fundamental analysis

No fundamental analysis for VVT Med Inc. yet.

VVT Med Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VVT Med Inc.

VVT Med Inc. develops, manufactures, and commercializes minimally invasive, non-thermal, and nontumescent solutions for the treatment of varicose veins. It offers V-BLOCK, a treatment kit for vein diameters; and ScleroSafe for combining negative pressure and mechano-chemical ablation in one smart systems. The company was incorporated in 2007 and is based in Kfar Saba, Israel.

Full company profile